Los Angeles Capital Management’s Radius Health, Inc. RDUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-61,290
Closed -$636K 1433
2022
Q2
$636K Buy
61,290
+11,410
+23% +$84.9K ﹤0.01% 877
2022
Q1
$440K Buy
49,880
+1,115
+2% +$8.45K ﹤0.01% 1090
2021
Q4
$337K Sell
48,765
-8,800
-15% -$129K ﹤0.01% 1199
2021
Q3
$714K Sell
57,565
-3,910
-6% -$56.4K ﹤0.01% 895
2021
Q2
$1.12M Buy
61,475
+43,710
+246% +$869K ﹤0.01% 806
2021
Q1
$371K Sell
17,765
-12,100
-41% -$255K ﹤0.01% 1355
2020
Q4
$533K Sell
29,865
-7,126
-19% -$107K ﹤0.01% 1182
2020
Q3
$419K Buy
36,991
+1,479
+4% +$18.3K ﹤0.01% 1154
2020
Q2
$484K Buy
35,512
+1,322
+4% +$18.2K ﹤0.01% 1119
2020
Q1
$444K Buy
34,190
+3,800
+13% +$67.8K ﹤0.01% 941
2019
Q4
$613K Buy
+30,390
New +$738K ﹤0.01% 967

Other funds holding RDUS

Los Angeles Capital Management's RDUS Position: Q3 2022 in Review

Los Angeles Capital Management sold out of Radius Health, Inc. (RDUS) in Q3 2022, closing a stake of 61,290 shares — an estimated $636K sold.

Los Angeles Capital Management first reported a position in RDUS in Q4 2019 and held it in 11 quarters. The position peaked at $1.12M in Q2 2021. 1 fund tracked by Wall St. Rank holds RDUS as of Q3 2022.

  • Los Angeles Capital Management reported no remaining Radius Health, Inc. position as of Q3 2022 after selling out during the quarter.
  • Los Angeles Capital Management sold 61,290 Radius Health, Inc. shares in Q3 2022, an estimated $636K.
  • Los Angeles Capital Management first reported a position in Radius Health, Inc. in Q4 2019 and held it in 11 quarters.
  • Los Angeles Capital Management's Radius Health, Inc. position peaked at $1.12M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held Radius Health, Inc. as of Q3 2022.

Based on Los Angeles Capital Management's 13F filing for Q3 2022, filed 2 Nov 2022.